Literature Citations
1. Design, Synthesis and Evaluation of Novel Indole-2-carboxamides for Growth Inhibition of Mycobacterium tuberculosis and Paediatric Brain Tumour Cells. Alsayed, S.S.R., S.C. Lun, A.W. Bailey, A. Suri, C.C. Huang, M. Mocerino, A. Payne, S.T. Sredni, W.R. Bishai, and H. Gunosewoyo. RSC Advances, 2021. 11(26): p. 15497-15511. ISI[000649193500001].
[WOS]. TB_06_2021.
2. In Vitro anti-Tb Properties, in Silico Target Validation, Molecular Docking and Dynamics Studies of Substituted 1,2,4-oxadiazole Analogues against Mycobacterium tuberculosis. Deb, P.K., N.A. Al-Shar'i, K.N. Venugopala, M. Pillay, and P. Borah. Journal of Enzyme Inhibition and Medicinal Chemistry, 2021. 36(1): p. 869-884. PMID[34060396]. PMCID[PMC8172222].
[PubMed]. TB_06_2021.
3. Targeting Mycobacterium tuberculosis CoaBC through Chemical Inhibition of 4'-Phosphopantothenoyl-L-cysteine synthetase (CoaB) Activity. Evans, J.C., D. Murugesan, J.M. Post, V. Mendes, Z. Wang, N. Nahiyaan, S.L. Lynch, S. Thompson, S.R. Green, P.C. Ray, J. Hess, C. Spry, A.G. Coyne, C. Abell, H.I.M. Boshoff, P.G. Wyatt, K.Y. Rhee, T.L. Blundell, C.E. Barry, 3rd, and V. Mizrahi. ACS Infectious Diseases, 2021. 7(6): p. 1666-1679. PMID[33939919]. PMCID[PMC8205227].
[PubMed]. TB_06_2021.
4. Antimicrobial Activity of Cyclic-Monomeric and Dimeric Derivatives of the Snail-derived Peptide Cm-p5 against Viral and Multidrug-resistant Bacterial Strains. González-García, M., F. Morales-Vicente, E.D. Pico, H. Garay, D.G. Rivera, M. Grieshober, L. Raluca Olari, R. Groß, C. Conzelmann, F. Krüger, F. Zech, C. Prelli Bozzo, J.A. Müller, A. Zelikin, H. Raber, D. Kubiczek, F. Rosenau, J. Münch, S. Stenger, B. Spellerberg, O.L. Franco, A.A. Rodriguez Alfonso, L. Ständker, and A.J. Otero-Gonzalez. Biomolecules, 2021. 11(5): 745. PMID[34067685]. PMCID[PMC8156702].
[PubMed]. TB_06_2021.
5. Phytochemistry, Antioxidant and Antibacterial Activities of Fruit Extracts of Myrsine africana L. Gul, H., G.K. Raja, M. Shahid, M. Iqbal, S. Irum, A. Agshar, D. Ahmad, and M. Gulfraz. Pakistan Journal of Pharmaceutical Sciences, 2021. 34(2): p. 507-512. ISI[000646853400003].
[WOS]. TB_06_2021.
6. 2,2,2-Trifluoro-1-(1,4,5,6-tetrahydropyridin-3-yl)ethanone Derivative as Efflux Pump Inhibitor in Mycobacterium tuberculosis. Halicki, P.C.B., J.S. Vianna, N. Zanatta, V.P. de Andrade, M. de Oliveira, M. Mateus, M.V. da Silva, V.J. Rodrigues, D.F. Ramos, and P.E. Almeida da Silva. Bioorganic and Medicinal Chemistry Letters, 2021. 42: 128088. PMID[33964440].
[PubMed]. TB_06_2021.
7. Chemical Constituents of Psidium guajava Leaves and Their Antibacterial Activity. Huang, J., C. Li, J. Ma, K. Xu, X. Chen, J. Jiang, and D. Zhang. Phytochemistry, 2021. 186: 112746. PMID[33799191].
[PubMed]. TB_06_2021.
8. In Vitro Activity of Oxazolidinone against Nontuberculous Mycobacteria, Including Macrolide-resistant Clinical Isolates. Kim, D.H., S.Y. Kim, W.J. Koh, and B.W. Jhun. Antimicrobial Agents and Chemotherapy, 2021. 65(7): e0230620. PMID[33903101].
[PubMed]. TB_06_2021.
9. A New Class of Linezolid-based Molecules as Potential Antimicrobial and Antitubercular Agents: A Rational Approach. Kushwaha, B., N.D. Kushwaha, T. Parish, J. Guzman, A. Kajee, M.S. Shaikh, I. Kehinde, V.A. Obakachi, T.K. Pathan, S.R. Shinde, and R. Karpoormath. ChemistrySelect, 2021. 6(13): p. 3065-3074. ISI[000656857900002].
[WOS]. TB_06_2021.
10. Promotion of Anti-tuberculosis Macrophage Activity by L-Arginine in the Absence of Nitric oxide. McKell, M.C., R.R. Crowther, S.M. Schmidt, M.C. Robillard, R. Cantrell, M.A. Lehn, E.M. Janssen, and J.E. Qualls. Frontiers in Immunology, 2021. 12: 653571. PMID[34054815]. PMCID[PMC8160513].
[PubMed]. TB_06_2021.
11. Anti-mycobacterium Compound Derived from Erythrobacter sp. Isolated from Callyspongia aurizusa. Murniasih, T., C.I. Cindhy, P.M. Yunovilsa, and E. Sukara. 3rd International Conference on Marine Science, 2020. 429: 012009. ISI[000649726300009].
[WOS]. TB_06_2021.
12. Synthesis, Characterization, DFT Modeling and in Vitro Antimycobacterial Activity Assays of a Silver(I)-isoniazid Complex. Paris, J.A., M. Cavicchioli, R.T.A. Machado, F. Pavan, D.H. Nakahata, P.P. Corbi, A.M.F. Costa, D.H. Pereira, and A.C. Massabni. Quimica Nova, 2021. 44(3): p. 278-283. ISI[000655052000003].
[WOS]. TB_06_2021.
13. Novel Stilbene Scaffolds Efficiently Target Mycobacterium tuberculosis Nucleoid-associated Protein, HU. Peraman, R., G. Meka, N.B. Chilamakuru, V.K. Kutagulla, S. Malla, C.R. Ashby, A.K. Tiwari, and P.R. Yiragamreddy. New Journal of Chemistry, 2021. 24; p. 10683-10692. ISI[000655228700001].
[WOS]. TB_06_2021.
14. In Vitro Potency of 2-(((2-Hydroxyphenyl)amino)methylene)-5,5-dimethylcyclohexane-1,3-dione against Drug-resistant and Non-replicating Persisters of Mycobacterium tuberculosis. Rather, M.A., Z.S. Bhat, A.M. Lone, M. Maqbool, B.A. Bhat, and Z. Ahmad. Journal of Global Antimicrobial Resistance, 2021. 25: p. 202-208. PMID[33789204].
[PubMed]. TB_06_2021.
15. Design, Synthesis and Biological Activity of N-(Amino)piperazine-containing Benzothiazinones against Mycobacterium tuberculosis. Wang, A., S. Xu, Y. Chai, G. Xia, B. Wang, K. Lv, C. Ma, D. Wang, A. Wang, X. Qin, M. Liu, and Y. Lu. European Journal of Medicinal Chemistry, 2021. 218: 113398. PMID[33823392].
[PubMed]. TB_06_2021.
Literature Citations
16. Antibacterial Quinolines. Pardal Filipe, A.E., C.P. Da Costa Pereira Rosa, A.V. Cordeiro Simoes, J.C. Ramos Damil, J.P. Silva Serra, A.L. Almeida Ferreira, R.I. Gomes Neves, and S.A. Marques Homem e Sousa dos Santos. Patent. 2021. 2020-IB62483 2021130732: 108pp.
[Patent]. TB_06_2021.
17. Compounds for the Treatment of Bacterial Infections and Potentiation of Antibiotics. Wang, B., D.W. Boykin, A. Kumar, M. Zhu, M. Roy Choudhury, and B. Yu. Patent. 2021. 2020-US66036 2021127452: 225pp.
[Patent]. TB_06_2021.